Skip to content
value.today

Hookipa Pharma Inc.

HOOKUnlisted company
$78 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
$20 M
annual
value.today research
Net income
$-44 M
-225.6% margin
value.today research
Employees
—

Hookipa Pharma Inc. in brief

Hookipa Pharma Inc. is an unlisted company in the Biotechnology industry, based in California, USA. It was founded in 2011. In its latest reported year it had sales of $20 M and a net loss of $44 M.

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Hookipa Pharma Inc.

Hookipa Pharma is a Clinical Stage Biopharmaceutical company developing a new class of immunotherapeutics based on a proprietary arenavirus platform that is designed to reprogram the body’s immune system. The company annual revenue is 19.6 million USD as on 2020. The headquarters is in USA.

Hookipa Pharma Inc. timeline

2 events, 2011–2019
  1. 2011
  2. 🏁
    · approximate
    Founded
  3. 2019
  4. 🔔
    · approximate
    Initial public offering on Nasdaq

Events of Hookipa Pharma Inc. from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

More about Hookipa Pharma Inc.

Acquisitions and changes
No longer listed: ticker HOOK is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).

Market cap history

$0 M$89 M$177 M$266 M$354 M20202021202220232024

World rank over time

▼ down 9,011 places since 2020
2020-01-01: #13661#13,66120202021-01-01: #13264#13,26420212022-01-07: #25442#25,44220222022-12-25: #25991#25,99120222023-07-30: #24331#24,33120232024-01-05: #22672#22,6722024

Rank in USA: #2,868 (Jan 2020) · #2,883 (Jan 2021) · #4,750 (Jan 2022) · #4,897 (Dec 2022) · #4,611 (Jul 2023) · #3,855 (Jan 2024)

Annual results

Revenue
$20 M
Operating income
—
Net income
$-44 M

Mutual funds holding Hookipa Pharma Inc.#

3 funds hold shares worth $0 M. Since their previous reports 0 added shares and 0 sold.
Mutual funds holding Hookipa Pharma Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Large-Cap Growth PortfolioPacific Life Fund Advisors LLC8,859$0 M—<0.01%no changeJun 30, 2026
🇺🇸 Guardian Large Cap Fundamental Growth VIP FundPark Avenue Institutional Advisers LLC2,270$0 M—<0.01%no changeJun 30, 2026
🇺🇸 AVIP Fidelity Institutional AM Equity Growth PortfolioCONSTELLATION INVESTMENTS INC679$0 M—<0.01%no changeJun 30, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jun 30, 2026. The 3 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Markets and events: Hookipa Pharma Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-05-29
10,611
1 days to cover
Shares sold short, last 24 reportsAll stocks →

Trading halts

  • 2025-07-18 20:01 UTC, code T3, resumed 20:35 UTC

Fails to deliver

  • : 95 shares at $1.15
  • : 95 shares at $1.09
  • : 99,995 shares at $0.84
  • : 1,236 shares at $0.94
  • : 62 shares at $1.48

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

How Hookipa Pharma Inc. compares in Biotechnology

  • Revenue$20 M · higher than 50% of 647
  • Net margin-225.6% · higher than 25% of 408

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Hookipa Pharma Inc.🇺🇸$78 M—-225.6%—
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Profile updated:
Nov 14, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Hookipa Pharma Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Hookipa Pharma Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Hookipa Pharma Inc.? Suggest a correction